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Abstract
Objective: To evaluate sexual function and quality of life 
features using two validated Female Sexual Function Index 
(FSFI) questionnaires, and the Short-Form Health Survey 
(SF-36) in patients with sexually active on Placenta Accreta 
Spectrum (PAS) Disorder patient. 
Methods: This research is a cross sectional analytic 
observational study which was conducted in Haji Adam 
Malik General Hospital from January 2017 - December 2019. 
Thirty-fi ve study patients who have been diagnosed with 
PAS disorder and have been treated for at least 3 months 
were divided into hysterectomy and conservative groups. 
This study data consisted of primary data from interviews 
and secondary data from medical records. Independent T 
test is used if it is normally distributed and Mann-Whitney 
is used if it is not normally distributed, and it is declared 
signifi cant if the P value is <0.05.
Result: From 8 assessment variables in the SF-36 
questionnaire by comparing the questionnaire scores of 
PASD patients in the hysterectomy and conservative groups 
by showing signifi cant results on social function (P value 
0.021). Whereas in the FSFI questionnaire, there were 6 
variables to assess the sexual function of patients with pain 
variable showing signifi cant results (P value 0.007).
Conclusions: There were differences in quality of life (social 
function) and sexual function (pain) in PASD patients in the 
hysterectomy and conservative groups.
Keywords: female sexual functional index, placenta accreta 
spectrum, quality of life, short-form health survey.
Abstrak
Tujuan: Untuk mengevaluasi fungsi seksual dan fi tur 
kualitas hidup dengan menggunakan dua kuesioner 
tervalidasi Female Sexual Function Index (FSFI), dan Short-
Form Health Survey (SF-36) pada pasien dengan placenta 
accrete spectrum (PAS) disorder yang aktif secara seksual 
setelah tindakan operasi.
Metode: Penelitian ini merupakan penelitian analitik 
observasional dengan metode potong lintang yang 
dilaksanakan di Rumah Sakit Umum Haji Adam Malik dari 
January 2017-December 2019. Tiga puluh lima pasien yang 
didiagnosis dengan spektrum plasenta akreta dan telah 
ditatalaksana minimal 3 bulan dibagi menjadi kelompok 
histerektomi and konservatif. Data penelitian ini terdiri atas 
data primer dari wawancara dan data sekunder dari rekam 
medis. Uji T independen digunakan jika berdistribusi normal 
dan Mann-Whitney digunakan jika tidak berdistribusi 
normal, serta dinyatakan signifi kan jika nilai P <0.05.
Hasil: Dari 8 variabel penilaian dalam kuesioner SF-36 
dengan membandingkan skor kuesioner pasien PASD 
pada kelompok histerektomi dan konservatif dengan 
menunjukkan hasil yang signifi kan pada fungsi sosial (nilai 
P = 0,021). Sedangkan dalam kuesioner FSFI terdapat 6 
variabel untuk menilai fungsi seksual pasien dengan variabel 
nyeri yang menunjukkan hasil yang signifi kan (nilai P = 
0,007).
Kesimpulan: Terdapat perbedaan dalam kualitas hidup 
(fungsi sosial) dan fungsi seksual (nyeri) pada pasien PASD 
di kelompok histerektomi dan konservatif. 
Kata kunci: indeks fungsional seksual perempuan, kualitas 
hidup, spektrum plasenta akreta, survey kesehatan singkat
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INTRODUCTION
Placenta Accreta Spectrum (PAS) disorder is a 
condition of the attachment of the placenta that 
is not normal to the uterus. Common and severe 
short-term PAS morbidity, including massive 
obstetric haemorrhage, need for emergency 
hysterectomy, intensive care unit admission, 
prolonged hospitalization, and even maternal 
death. The incidence of PAS has increased over 
the past 40 years from approximately 1 in 4,000 
in the 1980s to as high as 1 in 533. When this 
condition is diagnosed antenatally and women 
are referred to specialist centres for delivery, the 
outcome improves signifi cantly.1
In women with a fi nal diagnosis of placenta 
increta or percreta, the antenatal diagnosis is 
associated with reduced bleeding rates and 
reduced need for blood transfusions, possibly 
because women diagnosed antenatally are more 
likely to have preventive therapy for bleeding, 
and are less likely to attempt to remove their 
placenta. In addition, more than half of women 
with placenta accreta, increta, or percreta 
underwent hysterectomy.2
Although short-term PAS morbidity is 
suffi ciently described, there are limited data 
available regarding long-term health and quality 
of life after PAS surgery. Patients undergoing 
peripartum hysterectomy for other conditions 
may suffer from long-term depression, post-
traumatic stress disorder (PTSD), and sexual 
dysfunction. These long-term effects may be 
related to several factors including a wider 
surgical dissection leading to increased scarring 
and increased emotional burden caused by 
hysterectomy, loss of fertility.1
When patients choose a hysterectomy, they 
should be counselled by their doctor about 
their medical condition, reasons for surgery, 
planned surgical procedures, the expected 
recovery process, and potential long-term 
problems. Theoretically, removal of the uterus 
has the potential to affect the pelvic anatomical 
structures including the regional nerve supply. 
Lubrication and orgasm are thought to be related 
to the supply of nerves to the upper vagina and 
many nerves pass through the operating fi eld 
through the uterovaginal plexus. This plexus 
can be damaged during a hysterectomy, as a 
result, changes in sexual desire and orgasm can 
occur after hysterectomy. Hysterectomy can 
also be associated with loss of bodily integrity, 
loss of fertility (if the ovaries are removed), 
and psychosexual and socio-cultural problems 
including reduced partner intimacy and feelings 
of loss of femininity. After this operation, the lives 
of women may be affected in different domains 
and it is very important to assess the extent of 
this problem.3 
This study aims to evaluate sexual function and 
quality of life features using two validated Female 
Sexual Function Index (FSFI) questionnaires, and 
the Short-Form Health Survey (SF-36) in PAS 
patient with sexually active after hysterectomy or 
conservative surgery.
METHODS
This research is a cross-sectional analytic 
observational study that was conducted in Haji 
Adam Malik General Hospital from January 
2017-December 2019. Thirty-fi ve study subjects 
were collected by total sampling and divided 
into 2 groups based on their therapy which was 
the hysterectomy and non-hysterectomy groups. 
Patients who have been diagnosed with placenta 
accrete spectrum based on surgical fi ndings and 
histopathological confi rmation have been treated 
for at least 3 months were considered as study 
subjects. Patients who could not be interviewed 
because they could not be contacted or were 
unable to communicate and had incomplete 
medical records were excluded from this study. 
All eligible study subjects were called and 
interviewed by phone. All study subjects were 
asked to fi ll the validated Indonesian version 
FSFI and SF-36 questionnaires by google form 
which the link was sent through text message. 
There were 5 factors included in the assessment, 
such as arousal, stimulation, lubrication, orgasm, 
satisfaction and pain. If the score of FSFI was > 
26.5 was interpreted as no sexual dysfunction, 
while FSFI score < 26.5 was considered signifi cant 
sexual dysfunction. The SF-36 questionnaire 
measures eight scales: physical functioning, role 
physical, bodily pain, general health, vitality, 
social functioning, role emotional, and mental 
health. Each scale is directly transformed into a 
0-100 scale on the assumption that each question 
carries equal weight. The lower the score the more 
disability. The higher the score the less disability 
and a score of 100 is equivalent to no disability.
This study data consisted of primary data from 
interviews and questionnaire scores which were 
mean of FSFI and SF-36 scores, while secondary 
data from medical records, consisted of maternal 
age, gestational age, parity, PAS score, amount of 
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bleeding, urologic complication, neonatal death 
and duration of surgery. 
The study subjects’ characteristics are 
presented in frequency distribution table. The 
data was analyzed using Statistical Product and 
Service Solutions 24th version. Independent T-test 
is used if it is normally distributed and Mann-
Whitney is used if it is not normally distributed, 
and it is declared signifi cant if the P-value is 
<0.05.
RESULTS
Table 1. Sample Characteristic Based on Type of Surgery













































































n = 35, (100%)
Hysterectomy
n = 23 (65.7%)
Conservative
n = 12 (34.3%) P-value
From January 2017 to December 2019, 141 
patients were diagnosed with PASD. There are 4 
incomplete medical records and 2 patients died. 
There were 135 patients who met the inclusion 
and exclusion criteria. Then, there were 40 
cellphone numbers of the inactive patients. Of the 
95 patients that the researchers could contact, 38 
patients did not fi ll out the questionnaire (did not 
respond), 13 patients refused, and 35 patients 
fi lled out the questionnaire (response). 
From January 2017 to December 2019, 
141 patients were diagnosed
with PASD.
There are 4 incomplete medical records 
and 2 patients died.
There were 135 patients who met the
 inclusion and exclusion criteria
Then, there are 40 inactive cellphone 
numbers of the patient
Of the 95 patients that the researchers could contact, 38 patients did not fi ll out the questionnaire
(did not respond), 13 patients refused, and 35 patients fi lled out the questionnaire (response).
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In this study, data on patient characteristics 
assessed were maternal age, wherein the 
hysterectomy and conservative groups the 
majority were aged 20-35 years 16 (58.3%) and 7 
(41.7%) with a p-value of 0.506, the difference in 
gestational age in the histrectomy group 37 (36-
38) and conservative 38 (37-39) with p-value 0.000. 
The parity characteristics of these patients were 
dominated by multiparity, in the hysterectomy 
group 19 (76%) and the conservative group 6 
(24%) (p-value 0.217). PAS scores have signifi cant 
difference between two groups with PAS score 2 
In the table above, there are 8 assessment 
variables in the SF-36 questionnaire by comparing 
the questionnaire scores of PASD patients in 
the hysterectomy and conservative groups by 
showing signifi cant results on social function 
Whereas in the FSFI questionnaire, there were 6 
variables to assess the sexual function of patients 
with pain variable showing signifi cant results 
(p-value 0.007), other variables namely desire, 
arousal, lubrication, orgasm, and satisfaction did 
not show signifi cant results.
DISCUSSIONS
In this research on placenta accreta spectrum 
patients showed mean age of the patients 
in hysterectomy group was 32.9 + 4.1 years 
in the hysterectomy group and PAS score 0 in the 
conservative group. The mean bleeding between 
hysterectomy group was 1093.48 ± 71.12 and 
the conservative group 437.5 ± 48.26 (p-value 
0.000). Urologic complications were present 
in 2 patients in the hysterectomy group with p 
value 0.464. Neonatal death was only 1 case in 
the hysterectomy group with a p-value of 0.293. 
The difference in duration after surgery in the 
hysterectomy group was 6 (5-7) months and the 
conservative group was 3.5 (3-4) months (p-value 
0.000)
(p-value 0.021) while on physical functioning, 
role functioning (physical), role functioning 
(emotional), energy / fatigue, emotional 
wellbeing, social functioning, pain, and general 
health do not show signifi cant results.
compared to the conservative group was 31.7-
31.8 + 4.2-4.5 years. Meanwhile, for the number 
of parity there was a signifi cant difference 
between the hysterectomy and conservative 
groups (p <0.001) with the majority of the parity 
3-4 as much as 57.9%; followed by> 5 as much as 
36.8% and at least 5.3% with parity 1-2. Whereas 
in the conservative group, the majority appears 
with parity 1-2 (54.2% - 87.5%); followed by the 
parity 3-4 (12.5% - 45.8%); without patients with 
parity > 5.Based on previous C-section history, 
there was a signifi cant difference between the 
Table 2. Quality of Life Based on Short form (SF) – 36 Questionnaire
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hysterectomy and conservative groups (p <0.001) 
with the majority of 47.4% of hysterectomy 
patients having history of 3 times C-section, 
followed by 42, 1% with 4 times, and 10.5% as 
much as 2 times, whereas in the conservative 
group it appears that the majority of patients 
with a history of 2 times C-section (37.5% -50%), 
followed by 1 times (20,8%-50%), 37.5% 3 times 
and only 4.2% with a history of 4x C-section. 4
On 97 consecutive patients with PAS disorders 
that were treated in their hospital showed that 
mean patient age was 29.89 (range: 20 to 40) 
years. The average gestational week at pregnancy 
termination was 19.36 (range: 13 to 27+ 4) 
weeks. The median gravidity was 2, including 3 
nulliparous patients (10.3%). The most common 
risk factor was previous curettage operation 
(75.9%), followed by previous cesarean delivery 
(69.0%) and placenta previa (41.4%).5
On the placenta accreta spectrum patients 
showed that in the conservative group, the mean 
blood loss within 24 hours after surgery was 
signifi cantly lower than the hysterectomy (H) 
group (1518 ± 1275 vs 4309 ± 2550 ml in group 
H, p < 0.001 ). Patients with> 1000 ml blood loss 
in group H were more signifi cantly than in group 
C (93.6% [131/140] vs. 61.4% [86/140], p <.001). 
More patients received blood transfusions 
in group H than in group C (p = 0.014). There 
were no signifi cant differences between the two 
groups in terms of bladder injury, postoperative 
anemia, fever, and disseminated intravascular 
coagulation. The neonatal outcomes in the two 
groups showed no difference.6
The research which evaluated Quality of Life 
(QoL) after hysterectomy in placenta accreta (PAS) 
spectrum patients showed that patients with PAS 
experienced signifi cantly more continuous pain 
after 6 months post-partum on the SF-36 scoring. 
Specifi cally, women with accreta reported a 
“moderate” pain score over 4 weeks versus a “very 
mild” pain score mean for patients with cesarean 
complications. (p = 0.025). When adjusted for the 
SF-36 domain and compared the hysterectomy 
outcome between accreta patients and cesarean 
complications showed a physical function of 89.6 
vs 94.3 (p = 0.237), physical role function 80.4 vs 
91.4 (p = 0.197), emotional role function 76.2 vs 
88.6 (p = 0.175), energy and fatigue 48.1 vs 54.3 
(p = 0.346), emotional well-being 73.5 vs 78.3 (p 
= 0.411), social function 82 , 5 vs 89.5 (p = 0.241), 
pain 66.8 vs 83.4 (p = 0.013) and general health 
74.3 vs 74.9 (p = 0.929). From these results, it 
appears that the pain domain has a signifi cant 
difference between the hysterectomy group with 
placenta accreta spectrum indications compared 
to complications of cesarean section.7
There was a prospective cohort study of women 
with risk factors for PAS enrolled before birth. 
The correspondents are women who underwent 
cesarean hysterectomy due to PAS. At 6 months 
postpartum, women were at increased risk of re-
admission (odds ratio [OR] 5.83, 95% confi dence 
interval [CI] 1.40-24.3), post-coitus pain (OR 2.50, 
95% CI 1.04 6.02), anxiety / worry (OR 3.77, 95% CI 
1.43-9.93), but statistically not signifi cant for the 
likelihood of incidence of additional surgery (OR 
3.39, 95% CI 0, 99-11.7) or sadness and depression 
(OR 2.45, 95% CI 0.87 6.95). At 12 months, women 
with PAS were more likely to report post coitus 
pain, sadness / depression, and anxiety / worry. 
At a time duration of 36 months, women with PAS 
were more likely to report sadness / depression, 
anxiety / worry, and additional surgery. Women 
with PAS reported signifi cantly lower quality 
of life in the domains of physical function, role 
function, social functioning, and pain at 6 months 
postpartum, but not in other domains of quality 
of life. Decreased quality of life was also reported 
at 12 and 36 months post-hysterectomy in the 
PAS group.1
The present study at assessing sexuality after 
hysterectomy using the Female Sexual Function 
Index (FSFI) showed that Total FSFI score was 19.4 
± 3.6 (median 19.8) and for the domains: 3.2 ± 0.9 
(desire); 3.2 ± 0.9 (arousal); 3.1 ± 0.6 (lubrication); 
3.1 ± 0.7 (orgasm); 3.5 ± 1.1 (satisfaction) and 3.2 
± 1.2 (pain/dyspareunia). All women displayed 
sexual dysfunction (total FSFI score ≤ 26.55).8 
The long-term effects of hysterectomy affect 
psychological as well as physical health. Some 
studies reported that hysterectomy could lead 
to sexual dysfunction and depression.9 Concerns 
about sexual function are an important cause of 
anxiety for women undergoing hysterectomy. 
Indeed, 21 % of women with a mean age of 
59 stated that the uterus is important for their 
sexual experience and after hysterectomy 10–20 
% may experience deterioration of their sexual 
function. possible pathways for deleterious 
physical effects of hysterectomy: scar tissue 
in the vagina might prevent full ballooning of 
the upper vagina, removed tissue may reduce 
the capacity for vasocongestion and with or 
without nerve damage, this could reduce arousal 
or cause dyspareunia. Vaginal length was not 
related to sexual function. Experimental evidence 
confi rmed that hysterectomy caused sensory 
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loss in the vagina, without impacting sexual 
function.10 Women undergoing hysterectomy 
reported low normal level of vaginal lubrication 
that implied the potential sexual-mental 
arousal following the hysterectomy although 
no signifi cant difference was found between 
groups undergoing hysterectomy and groups 
with fi broids but not undergoing hysterectomy 
in terms of sexual arousal women with a history 
of radical hysterectomy showed a signifi cant 
decrease in maximum vaginal pulse amplitude 
during sexual arousal, and the variation in vaginal 
pulse amplitude during sexual arousal occurred 
with regard to the fact that all the patients 
experienced equally strong sexual arousal.11 
However, studies of sexual function assessed 
by FSFI in placenta accreta patients undergoing 
hysterectomy have not been found.
CONCLUSION
There were differences in quality of life (social 
function) and sexual function (pain) in PASD 
patients in the hysterectomy and conservative 
groups.
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